Madrigal Pharmaceuticals poised for market dominance with Rezdiffra’s first full quarter… EP News Bureau Aug 12, 2024 As per the GlobalData report, as Rezdiffra secures its position as a first-line treatment for MASH, Madrigal Pharmaceuticals eyes…
